Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Join your colleagues from Idaho, Nevada, New Mexico, Utah, and Wyoming on September 6th and 7th for a weekend of hot topics in cardiovascular care including heart failure, amyloid, prevention, clinician wellness, atrial fibrillation, and more! CME/CNE/MOC credits will be provided. We look forward to a wonderful weekend of networking and learning together at the Park City, Utah.
For more information and to register, please visit: ACC Rockies Chapter Meeting 2024
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Systolic BP Polygenic Risk Score With Chlorthalidone ResponseWhat is the ability of a systolic blood pressure (SBP) polygenic risk score (PRS) to predict antihypertensive treatment (AHT) response and apparent treatment-resistant hypertension (aTRH)?
- CONFIRM2: AI-Guided QCT May Help Reduce CV Events in Patients With Suspected CADAI-guided Quantitative Coronary Computed Tomography Angiography (AI-QCT) may help guide tailoring of anti-atherosclerotic therapies or coronary interventional procedures to reduce cardiovascular events in patients with suspected coronary artery disease (CAD), based on findings from the CONFIRM-2 trial presented at TCT 2024.
- Percutaneous Coronary Intervention With a Bioadaptor Compared to a Contemporary Drug-Eluting StentThe goal of the INFINITY-SWEDEHEART trial was to compare the efficacy of the DynamX bioadaptor, a novel coronary implantable device, to a contemporary drug-eluting stent (DES) in the treatment of coronary artery disease requiring percutaneous coronary intervention (PCI).
- Effectiveness and Safety of Early Administration of Heparin at First Medical Contact for STEMI Patients Undergoing Primary Percutaneous Coronary InterventionThe goal of the HELP-PCI trial was to determine the efficacy and safety of administering unfractionated heparin at first medical contact versus during cardiac catheterization only in patients with ST-segment elevation myocardial infarction (STEMI).
- HELP-PCI: Unfractionated Heparin at First Medical Contact vs. the CathlabPretreatment of STEMI patients with a loading-dose of unfractionated heparin (UFH) at first medical contact (FMC) vs. in the catheterization lab (cathlab) was associated with improved spontaneous reperfusion of the infarct-related artery (IRA) without increasing the risk of major bleeding...